SCHEMBL8309514

SCHEMBL8309514

CCOCCCSc1ccc(-c2ccnc(Nc3ccc(C(=O)N4CCN(CC(=O)NC(C)C)CC4)cc3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 3/20 0.45
▸ HDAC1 Q13547 2/20 0.45
▸ HDAC6 Q9UBN7 2/20 0.45
▸ IKBKB O14920 6/20 0.43
▸ CHUK O15111 6/20 0.43
▸ IKBKG Q9Y6K9 6/20 0.43
▸ CDK1 P06493 2/20 0.42
▸ CDK2 P24941 2/20 0.42
▸ MYLK4 Q86YV6 2/20 0.42
▸ STK17A Q9UEE5 2/20 0.42
▸ NEK3 P51956 1/20 0.42
▸ LIMK1 P53667 1/20 0.42
▸ NEK5 Q6P3R8 1/20 0.42
▸ JAK3 P52333 1/20 0.41
▸ MTOR P42345 1/20 0.40
▸ SMG1 Q96Q15 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CCNK O75909 2/20 0.40
▸ CDK12 Q9NYV4 2/20 0.40
▸ DYRK2 Q92630 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14021069 0.91 JAK2 (0.46) JAK2HDAC1HDAC6IKBKBCHUK
SCHEMBL8313394 0.91 IKBKB (0.46) JAK2HDAC1HDAC6IKBKBCHUK
SCHEMBL14063854 0.90 CDK2 (0.46) JAK2HDAC1HDAC6IKBKBCHUK
SCHEMBL8308934 0.87 IKBKB (0.45) JAK2HDAC1HDAC6IKBKBCHUK
SCHEMBL14063861 0.87 IKBKB (0.47) JAK2HDAC1HDAC6IKBKBCHUK
SCHEMBL8308363 0.85 IKBKB (0.50) IKBKBCHUKIKBKGDYRK2
SCHEMBL14063869 0.85 CDK1 (0.44) JAK2HDAC1HDAC6IKBKBCHUK
SCHEMBL14021585 0.85 CDK1 (0.53) JAK2HDAC1HDAC6IKBKBCHUK
SCHEMBL8313889 0.83 IKBKB (0.44) JAK2IKBKBCHUKIKBKGCDK1
SCHEMBL14021233 0.83 CDK1 (0.49) JAK2HDAC1HDAC6IKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 — — WO disclosed
Send feedback